Oncolytic virus therapy is a promising treatment option for cancer patients, utilizing viruses to target and destroy cancer cells. While this innovative approach has shown great potential in clinical trials, there are some side effects that patients should be aware of.
One common side effect of oncolytic virus therapy is flu-like symptoms, including fever, chills, and fatigue. These symptoms typically occur within the first few days after treatment and can last for several days. In some cases, patients may also experience nausea, vomiting, or diarrhea as their immune system responds to the virus.
Side effects may vary according to the type of oncolytic virus—and what exactly it targets—and may also be influenced by the location and type of cancer as well as a patient’s overall health. Due to their potential to infect healthy cells as well as stimulate overall immune activity, sometimes oncolytic viruses may cause the immune system to attack healthy cells, and their use may carry some risk of infection. Patients should always consult their doctors and the rest of their care team to gain a better and fuller understanding of the potential risks and side effects associated with specific oncolytic viruses.
